BDSX
Price
$15.06
Change
+$0.26 (+1.76%)
Updated
Jun 12 closing price
Capitalization
155.96M
59 days until earnings call
Intraday BUY SELL Signals
PLSE
Price
$24.37
Change
-$2.52 (-9.37%)
Updated
Jun 12 closing price
Capitalization
1.69B
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDSX vs PLSE

Header iconBDSX vs PLSE Comparison
Open Charts BDSX vs PLSEBanner chart's image
BDSX vs PLSE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDSX vs. PLSE commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDSX is a StrongBuy and PLSE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (BDSX: $15.06 vs. PLSE: $24.37)
Brand notoriety: BDSX and PLSE are both not notable
BDSX represents the Medical Specialties, while PLSE is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BDSX: 33% vs. PLSE: 125%
Market capitalization -- BDSX: $155.96M vs. PLSE: $1.69B
BDSX [@Medical Specialties] is valued at $155.96M. PLSE’s [@Pharmaceuticals: Other] market capitalization is $1.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $145.58B to $0. The average market capitalization across the [@Medical Specialties] industry is $15.03B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDSX’s FA Score shows that 0 FA rating(s) are green whilePLSE’s FA Score has 0 green FA rating(s).

  • BDSX’s FA Score: 0 green, 5 red.
  • PLSE’s FA Score: 0 green, 5 red.
According to our system of comparison, BDSX is a better buy in the long-term than PLSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDSX’s TA Score shows that 5 TA indicator(s) are bullish while PLSE’s TA Score has 5 bullish TA indicator(s).

  • BDSX’s TA Score: 5 bullish, 4 bearish.
  • PLSE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BDSX is a better buy in the short-term than PLSE.

Price Growth

BDSX (@Medical Specialties) experienced а -2.59% price change this week, while PLSE (@Pharmaceuticals: Other) price change was -3.79% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.27%. For the same industry, the average monthly price growth was +8.03%, and the average quarterly price growth was -5.20%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.49%. For the same industry, the average monthly price growth was +1.13%, and the average quarterly price growth was -15.35%.

Reported Earning Dates

BDSX is expected to report earnings on Aug 12, 2026.

PLSE is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Medical Specialties (-0.27% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-0.49% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLSE($1.69B) has a higher market cap than BDSX($156M). BDSX YTD gains are higher at: 121.471 vs. PLSE (77.495). BDSX has higher annual earnings (EBITDA): -18.34M vs. PLSE (-77M). PLSE has more cash in the bank: 68.3M vs. BDSX (25.6M). PLSE has less debt than BDSX: PLSE (7.16M) vs BDSX (71.6M). BDSX has higher revenues than PLSE: BDSX (96.1M) vs PLSE (751K).
BDSXPLSEBDSX / PLSE
Capitalization156M1.69B9%
EBITDA-18.34M-77M24%
Gain YTD121.47177.495157%
P/E RatioN/AN/A-
Revenue96.1M751K12,796%
Total Cash25.6M68.3M37%
Total Debt71.6M7.16M1,001%
FUNDAMENTALS RATINGS
PLSE: Fundamental Ratings
PLSE
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDSXPLSE
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
BDSX
Daily Signal:
Gain/Loss:
PLSE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WWWFX83.550.80
+0.97%
Kinetics Internet No Load
HCMIX37.470.35
+0.94%
HCM Tactical Plus I
TGPEX12.460.07
+0.56%
T. Rowe Price Global Impact Equity Inv
BROKX25.440.13
+0.51%
BlackRock Advantage International K
MACGX16.29-0.01
-0.06%
Morgan Stanley Inst Discovery A

BDSX and

Correlation & Price change

A.I.dvisor tells us that BDSX and ELMD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDSX and ELMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDSX
1D Price
Change %
BDSX100%
+1.76%
ELMD - BDSX
30%
Poorly correlated
-1.25%
RVTY - BDSX
26%
Poorly correlated
-1.83%
PLSE - BDSX
25%
Poorly correlated
-9.37%
WRBY - BDSX
24%
Poorly correlated
+2.32%
SMTI - BDSX
24%
Poorly correlated
-3.21%
More

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with XRAY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-9.37%
XRAY - PLSE
38%
Loosely correlated
-0.49%
NVST - PLSE
38%
Loosely correlated
+0.41%
CERS - PLSE
38%
Loosely correlated
-1.16%
CLPT - PLSE
32%
Poorly correlated
-2.89%
ARAY - PLSE
32%
Poorly correlated
+0.38%
More